Loading
NASDAQFinancial ServicesShell Companies
Latest quote
$10.23
+$0.02 · +0.20%
Harvard Ave Acquisition Corporation, established in 2024 and headquartered in Seoul, South Korea, is dedicated to pursuing and finalizing various strategic business combinations. This encompasses a range of corporate transactions such as mergers, asset or share acquisitions, recapitalizations, or broader reorganizations with other entities.
Previous close
$10.23
+$0.02 · +0.20%
Regular session · ET · Market data may be delayed.
Harvard Ave Acquisition Corporation, established in 2024 and headquartered in Seoul, South Korea, is dedicated to pursuing and finalizing various strategic business combinations. This encompasses a range of corporate transactions such as mergers, asset or share acquisitions, recapitalizations, or broader reorganizations with other entities.
Day range
Current $10.23
52-week range
Current $10.23
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
45
Fair Value
Sentiment
53
Mixed
Risk
11
Low Risk
Momentum
41
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Harvard Ave Acquisition Corporation, established in 2024 and headquartered in Seoul, South Korea, is dedicated to pursuing and finalizing various strategic business combinations. This encompasses a range of corporate transactions such as mergers, asset or share acquisitions, recapitalizations, or broader reorganizations with other entities.
Day range
Current $10.23
52-week range
Current $10.23
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Selling, general, and administrative | — | 57.02 USD |
| Operating expenses | 192.75 USD | 57.02 USD |
| Interest income | 705.77 USD | — |
| Operating income | −192 USD | −57.02 USD |
| Net income | 513.02 USD | −57.02 USD |
Company facts updated Sep 13, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
